Controversies on Lung Cancer: Pros and Cons
Debate 6: What is better/reliable, mitosis counting or Ki67/MIB1 staining? (Vol 5, No 5)
Debate 5: Can tissue biopsy be replaced by liquid biopsy? (Vol 5, No 4)
Debate 4. Should a patient with stage IA non-small cell lung cancer undergo invasive mediastinal staging? (Vol 5, No 3)
Debate 3. Does concurrent chemo-radiotherapy remain the ideal treatment in fit patients with large volume unresectable stage III non-small cell lung cancer? (Vol 5, No 2)
Pros: concurrent chemo-radiotherapy remains the ideal treatment in fit patients with large volume unresectable stage III non-small cell lung cancer
Cons: concurrent chemo-radiotherapy remains the ideal treatment in fit patients with inoperable large volume stage III non-small cell lung cancer
Rebuttal from Prof. Kong and Dr. Rabatic
Rebuttal from Prof. Rodrigues
Debate 2. Should a medically inoperable patient with a T2N0M0 non-small cell lung cancer central in the lung hilus be treated using stereotactic body radiotherapy? (Vol 4, No 5)
Pros: should a medically inoperable patient with a T2N0M0 non-small cell lung cancer central in the lung hilus be treated using stereotactic body radiotherapy?
Cons: should a medically inoperable patient with a T2N0M0 non-small cell lung cancer central in the lung hilus be treated using stereotactic body radiotherapy?
Rebuttal from Ms Woodford and Dr Senthi
Rebuttal from Dr Nestle and Dr Belderbos
Debate 1. Should long-term CT scan follow-up be the standard of care in patients who are curatively treated for an early-stage non-small cell lung cancer? (Vol 4, No 4)
Exploring controversies in lung cancer using structured pro-con debates
Pros: long-term CT scan follow-up should be the standard of care in patients who are curatively treated for an early-stage non-small cell lung cancer
Cons: long-term CT-scan follow-up is not the standard of care in patients curatively treated for an early stage non-small cell lung cancer
Rebuttal from Dr Hanna
Rebuttal from Dr van Meerbeeck
| 1 - 7 of 7 Items |
Disclosure:
The series “Controversies on Lung Cancer: Pros and Cons” was commissioned by the Editorial office, Translational Lung Cancer Research without any sponsorship or funding. Suresh Senan and Helmut H. Popper served as the unpaid Guest Editors for the series.